|
NEWARK E.M.A. HIV HEALTH SERVICES
PLANNING COUNCIL The Newark EMA
HIV Health Services Planning Council’s RESOLUTION on harm reduction and
needle/syringe exchange Adopted by the Planning
Council, March 17,1999 The
Newark EMA HIV Health Services
Planning Council was created by the federal Ryan White CARE Act --
legislation that provides for medical and social support services for
people living with HIV disease and their families.
The Planing Council is a body of 30 non-paid representatives, with
expertise in the field of HIV/AIDS care and treatment, who are responsible
for undertaking the Planning Council’s mandates (as per the CARE Act);
namely. the establishment of priorities for the $14.3 million received by
the Newark EMA.
Members of the Planning Council represent State and local health
agencies, community-based organizations including AIDS Service providers
or the local community affected by HIV.
A third of the people on the Council are people living with HIV or
AIDS.
WHEREAS,
as of December 31, 1998, 26,238 New Jerseyans, including 10,397
people from the five counties of the Newark EMA (Essex, Morris, Sussex
Union and Warren) are living with HIV or AIDS; and WHEREAS,
the cumulative AIDS Cases in New Jersey (37,517) ranks this state 5th
in the nation; and WHEREAS,
one half of New Jersey’s HIV infections are directly caused by
the sharing of contaminated syringes by injection drug users and an
additional one quarter of infections are indirectly caused by the
sharing of contaminated syringes; and WHEREAS,
New Jersey has the third highest rate of injection-related HIV in the
United States; and WHEREAS,
the prevalence of HIV/AIDS was higher among persons entering drug
treatment in a large Newark agency than among persons in any of 20 other
drug treatment agencies studied by the Centers for Disease Control in
1997; and WHEREAS,
New Jersey has a greater percentage of AIDS cases among women (28% of
cumulative AIDS cases; but 35% of AIDS cases reported in 1998) than any
other state; and WHEREAS,
New Jersey is third in terms of pediatric AIDS cases in the United States;
and WHEREAS,
New Jersey has two cities (Newark and Jersey City) on the top ten list of
United States cities with the highest rate of AIDS per capita; and WHEREAS,
among those who inject drugs, African-Americans are five times more likely
than whites to get AIDS, and Latinos are at least one and a half times as
likely as whites to get AIDS; and WHEREAS,
in light of the disproportionate impact of injection drug-related HIV on
communities of color, the continuing inaction to implement effective HIV
prevention targeting this group undermines the credibility of the State of
New Jersey and the Federal government’s stated goal of reducing racial
and ethnic health disparities; and WHEREAS,
the Centers for Disease Control estimated that in 1997 there were 46,000
injection drug users in New Jersey who were not yet infected with HIV; and WHEREAS,
New Jersey is the only state in the northeast United States without legal
provisions for syringe exchange; and WHEREAS,
there is still, as there has always been, inadequate treatment slots for
drug users willing and able to access effective treatment; and WHEREAS,
the medical field and public policy regard drug addiction as a chronic,
relapsing disease; and WHEREAS,
over 113 needle/syringe exchange programs exist in 30 states exchanging
17.5 million syringes annually; and WHEREAS,
the National Institutes of Health Consensus Panel reviewed studies on the
effectiveness of syringe exchange programs and concluded that syringe
exchange programs do not increase syringe injecting behavior among current
drug users, do not increase the number of drug users, and do not increase
the amount of discarded drug paraphernalia.
In addition, the NIH stated that “legislative restriction on
[syringe exchange programs] must be lifted.
Such legislation constitutes a major barrier to realizing the
potential of a powerful approach and exposes millions of people to
unnecessary risk;” and WHEREAS,
syringe exchange is supported by the following national organizations:
American Academy of Pediatrics, American Academy of Psychiatrists in
Alcoholism and Addictions, American Bar Association, American Medical
Association, American Pharmaceutical Association, American Psychiatric
Association, American Public Health Association, American Society of
Addiction Medicine, Association of State and Territorial Health Officials,
Congressional Black Caucus, NAACP, National Academy of Sciences, National
Association of Psychiatric Health Systems, National Association of Social
Workers, National Association of State Alcohol and Drug Abuse Directors,
Latino Committee on AIDS, National Black Caucus of State Legislatures,
U.S. Conference of Mayors, World Health Organization, and National Black
Police Association; and WHEREAS,
syringe exchange is supported by the following New Jersey-based
organizations: NJ Harm
Reduction Coalition, NJ Women and AIDS Network, NJ Medical Society, NJ
Public Health Association, NJ State Nurses Association, Association of
Nurses in AIDS Care, Association of Social Workers in AIDS Care,
Governor’s Advisory Council on AIDS, Hyacinth AIDS Foundation, NJ
American Civil Liberties Union, NJ HIV Prevention Community Planning
Group, NJ National Organization of Women, Hudson County HIV/AIDS Services
Planning Council, and the Paterson – Passaic County – Bergen County
HIV Health Services Planning Council; and NOW,
THEREFORE, BE IT RESOLVED, that the Newark EMA HIV Health Services
Planning Council in recognition of the overwhelming humanitarian and
public health imperative, supports harm reduction in its widest
interpretation including the immediate establishment of legal syringe
exchange and relaxing of drug paraphernalia laws (to allow for the
purchase of clean needles/syringes over the counter) in New Jersey as a
component of a comprehensive HIV and other blood-borne disease prevention
program. BE
IT FURTHER RESOLVED that these needle/syringe exchange programs include
drug and HIV education as well as referrals to the range of social and
medical services including drug treatment.
They must also be established with the cooperation of law
enforcement officers and demonstrate acceptance by community and religious
groups as well as local government. BE
IT FURTHER RESOLVED that the Newark EMA HIV Health Services Planning
Council urges State and local leaders and elected officials to show
compassion and take the lead in removing all impediments to the
implementation of needle/syringe exchange and other proven public health
interventions to save the lives of injecting drug users at risk of HIV and
other blood borne infections. References1. New Jersey Harm Reduction Coalition, John Mackin, P.O. Box 1459, New Brunswick, NJ 08903, 1998 2.
“PACHA
resolution on Needle Exchange Programs,” March 17, 1998 3.
United
States Conference of Mayors Adopts Resolution:
“Rationale for Needle Exchange Programs”, US Conference of
Mayors, 1620 Eye Street, NW, Washington, D.C., 20006, August 1997 4.
“Health
Emergency 1999, The Spread of Drug-Related AIDS and other Deadly Diseases
among African Americans and Latinos,” Dawn Day, Ph.D., Dogwood Center,
PO Box 187, Princeton, NJ, 08542 5.
“NJPHA
Position Paper: Supporting Needle Exchange to Reduce HIV Transmission,”
1995 6.
Unpublished
public testimony, Riki Jacobs, Executive Director of the Hyacinth AIDS
Foundation, 1999 7.
“Recommendation
Supporting Clean Needle Availability”, Governor’s Advisory Council on
AIDS, 1996 8.
Resolution
from the Hudson County HIV/AIDS Services Planning Council, January 6,
1999. 9.
“Hard
Line on Needle Exchanges”, David Kocieniewski, New York Times February
2, 1999. 10.
“Studies
of needle program called flawed,” Cinda Becker, Home News, February 4,
1999. 11. “Whitman’s wrong to ignore health value of needle exchange,” Rev. Benjamin Evans, President, Association of Nurses in AIDS Care, Jersey Journal, February 4, 1999. |